Gynecologic Cancer
News
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer
Major Finding: Compared with patients assigned to chemotherapy plus placebo, patients assigned to chemotherapy plus bevacizumab had a 52%...
News
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer
Major Finding: Compared with patients assigned to chemotherapy plus placebo, patients assigned to chemotherapy plus bevacizumab had a 52%...
Video
Video Report: A Drug for Ovarian Cancer?
News
Screening Does Not Reduce Ovarian Cancer Mortality
Major Finding: Among women who underwent screening with the CA 125 blood test and transvaginal ultrasound, 118 died of ovarian cancer, whereas 100...
News
Screening Does Not Reduce Ovarian Cancer Mortality
Major Finding: Among women who underwent screening with the CA 125 blood test and transvaginal ultrasound, 118 died of ovarian cancer, whereas 100...
News
Antiviral Cidofovir May Enhance Therapies for HPV-Related Cancers
Major Finding: Cidofovir appears to increase the sensitivity of cervical carcinomas to the effects of radiotherapy and chemotherapy.
News
PARP Inhibitor Olaparib Delays Progression in Ovarian Cancer
Major Finding:Maintenance therapy with olaparib extended progression-free survival to 8.4 months vs. 4.8 months with placebo. Data Source:...
News
Three-Year Interval Safe for Cervical Cancer Screening after Negative HPV Test
Major Finding: The 5-year risk of cancer with a negative HPV test and a negative Pap smear was 3.2/100,000 women per year, but the difference...
News
Gynecologic Cancer Symptoms May Be More Severe in Women With Psychiatric Histories
Major Finding: In a broad sampling of women with gynecologic cancer both on and off treatment, 32% reported clinically significant pain; 32%,...
News
BRCA2 Gene Mutation Linked With Improved Survival in Ovarian Cancer
Major Finding: The 5-year survival was 36% in those with no BRCA mutation, 46% in those with the BRCA1 mutation, and 61% in those with the BRCA2...
News
Fewer Than Half of Ovarian Cancer Patients Get Care Consistent with NCCN Guidelines
Major Finding: Care consistent with National Comprehensive Cancer Care guidelines was provided to 43% of 96,802 women with ovarian cancer.Data...